Overview

IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
A multi-centre randomised controled single blind clinical phase IV trial with the aim to determine the most effective treatment in terms of lesion reduction, costs and patient satisfaction in treatment of actinic keratosis (AK), when comparing topical treatment with photodynamic therapy (PDT), 5% 5-fluorouracil (5-FU) cream, 5% Imiquimod (IMI) cream and ingenol mebutate (IM) gel.
Phase:
Phase 4
Details
Lead Sponsor:
Maastricht University Medical Center
Treatments:
Aminolevulinic Acid
Fluorouracil
Imiquimod
Methyl 5-aminolevulinate